Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors

Author： Lim Joline S. J.   Tan David S. P.  

Publisher： MDPI

E-ISSN： 2072-6694|9|8|109-109

ISSN： 2072-6694

Source： Cancers, Vol.9, Iss.8, 2017-08, pp. : 109-109

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 520-533

Bentham Science Publishers

Access to resources Recommend Favorite

PARP Inhibitors in Ovarian Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 13, Iss. 4, 2018-11 ,pp. : 392-410

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 8, 2010-10 ,pp. : 593-600

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Resistance in Melanoma: Mechanisms, Apoptosis, and New Potential Therapeutic Targets

By Grossman D.  

Cancer and Metastasis Reviews, Vol. 20, Iss. 1-2, 2001-03 ,pp. : 5-13

Springer Publishing Company

Access to resources Recommend Favorite

Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options

By  

Current Cancer Therapy Reviews, Vol. 11, Iss. 4, 2015-12 ,pp. : 269-291

Bentham Science Publishers

Access to resources Recommend Favorite